Regeneron Pharmaceuticals shares owned by Ballentine Partners
Quarter-by-quarter ownership of Regeneron Pharmaceuticals (REGN) shares owned by Ballentine Partners
from 13F filings
Historical chart of Ballentine Partners investment in Regeneron Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Regeneron Pharmaceuticals held by Ballentine Partners consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Regeneron Pharmaceuticals by Ballentine Partners
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-03-31 | $1.0M | 1.0k | 962.48 |
| 2023-12-31 | $663k | 755 | 878.29 |
| 2023-09-30 | $820k | 996 | 822.96 |
| 2023-06-30 | $512k | 713 | 718.54 |
| 2023-03-31 | $918k | 1.1k | 821.67 |
| 2022-12-31 | $559k | 775 | 721.49 |
| 2022-09-30 | $399k | 581 | 687.50 |
| 2022-06-30 | $207k | 348 | 593.41 |
| 2022-03-31 | $263k | 378 | 695.12 |
| 2016-06-30 | $182k | 638 | 285.71 |
| 2016-03-31 | $225k | 625 | 360.25 |